
Fine lacquerware puts new sheen on Gaya craftsmanship
CHANGWON, South Gyeongsang Province — A decade since an archaeological excavation, government researchers are now shedding light on ancient craft-making in the southern part of Korean Peninsula.
'This dish on high pedestal demonstrates the sophistication of Korean craft some 2,000 years ago,' Kim Ji-yeon, a researcher at the Gaya National Research Institute of Cultural Heritage, told reporters as she held a dish on a pointed stand Monday.
Kim is a member of a Korea Heritage Service-run team that studies discoveries related to Gaya (42-562), a confederacy of city-states that was later annexed by the Silla Kingdom (57 BC–935 AD). The team, launched in 2015, believes its findings could reshape our understanding of the ancient confederacy, from everyday life to life in the palace.
The lacquered Gaya dish on a pointed stand, Kim said, shows exceptional craftsmanship: The stem connecting the dish and the base is the thinnest in East Asia, and the mounted dish, stem and base were crafted out of a single wooden piece, a technologically more challenging feat compared to creating the parts separately and joining them later.
The dish on a pointed stand was one of the 15 artifacts whose discovery was announced Monday, lacquered wooden dishwares excavated at the end of last year at a site in Bonghwa-dong in Gimhae, South Gyeongsang Province.
Digging at the site, the Gaya palace grounds, began in 2015. The artifacts were moved to nearby Changwon where the Gaya National Research Institute showcased them in tightly-sealed glass boxes.
The artifacts are thought to have been used for ancestral rites and likely made between the first and fourth centuries, according to Kim.
'It's also quite unusual to see all these 15 pieces in good condition overall,' Kim said of the pieces, made of East Asian alder wood, which is resistant to the effects of bad weather.
In addition to the 15 artifacts, the institute excavated some 300 items of wooden lacquerware including dishware, household items and farming tools. They, too, were made between the first and fourth centuries, according to the institute.
The Gimhae excavation project is expected to run through 2027 as researchers identify the artifacts.
Meanwhile, the Korea Heritage Service opened a storage facility inside an abandoned tunnel in Haman-gun in South Gyeongsang Province to store relics found nearby.
The Mogok Tunnel storage marks the fourth of its kind since 2021, and the agency said it will build a nationwide network of storage facilities as demand for them grows.
Lee Jong-hoon, the KHS director general, likened storage facilities to 'cultural stations,' saying residents nearby can drop by to see not only artifacts but interactive exhibitions related to them, as well.
siyoungchoi@heraldcorp.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Korea Herald
14 hours ago
- Korea Herald
Interview: Breaking boundaries in AI-powered life sciences
Baek Min-kyung, AI-driven protein expert, honored with APEC award for pioneering work in structural biology In the rapidly evolving field of artificial intelligence-powered life sciences, Baek Min-kyung, assistant professor of department of biological sciences at Seoul National University, is making waves for pushing the boundaries of protein structure prediction and design. As the winner of this year's APEC Science Prize for Innovation, Research and Education, or Aspire, she shared her vision for inclusive biotechnology that addresses global challenges. She is the first Korean to receive the award since professor Kug Jong-seong of Seoul National University, who was honored in 2015 for his El Nino prediction model. 'The Aspire award reflects the collective effort of colleagues who have shared the challenges and breakthroughs along the way,' she said. 'I find it especially meaningful that our accomplishments in protein structure prediction and design have been recognized for their social value. I hope to continue leveraging AI technologies to better understand the complexities of life and to conduct research that contributes to solving societal problems.' Her flagship innovation, RoseTTAFold, is an AI-based model capable of predicting the 3D structures of proteins. It has already been applied across biological research, drug discovery and vaccine design. 'I am expanding beyond predicting static, single structures to exploring multiple conformations of proteins, predicting protein–protein and protein–nucleic acid interactions and designing novel biomolecules with desired functions,' she explained. The Aspire award's 2025 theme -- "Toward AI-Bio Convergence: AI-based Inclusive Biotechnology Solving Social Challenges" -- resonates deeply with her research philosophy. For her, 'inclusive biotechnology' means ensuring that cutting-edge life science tools benefit a broad range of diseases and populations. Projects in her lab have included designing vaccine antigens for infectious diseases and predicting the structures of proteins linked to rare or under-researched conditions. Behind her success lies a guiding principle: Research should be both intellectually stimulating and socially relevant. She credits her growth as a cross-disciplinary scientist to the freedom and mentorship she received during her graduate and postdoctoral years. 'Convergence research often takes time to yield results and I was fortunate to have mentors who encouraged risk-taking rather than rushing the process,' she said. Looking ahead, she sees vast potential for international collaboration, particularly among young scientists in the Asia-Pacific Economic Cooperation region. 'Open sharing of data and tools, along with diverse perspectives, can inspire new ideas and innovative joint projects,' she said, underscoring the importance of sustained communication and trust. To early-career scientists, her advice is both practical and encouraging: 'Research often requires long periods of reflection and trial-and-error, but it is also deeply rewarding. Even small exchanges of ideas across disciplines can spark collaborations that address big challenges.' Her journey has not been without obstacles. Coming from a chemistry background, she initially found integrating AI into her work daunting. 'Rather than studying AI in isolation, I looked for ways to bridge the conceptual gap between AI and protein research,' she recalled. 'Interdisciplinary research is not just about placing two fields side by side -- it's about understanding each other's language and bridging the gaps creatively.' As AI continues to reshape science, she believes it will act as both a research accelerator and a catalyst for discovery -- enabling tasks once thought impossible and opening doors to entirely new scientific frontiers. 'That said,' she cautioned, 'we must address data quality, result interpretation and ethical issues to ensure AI's positive and lasting impact.' yeeun@


Korea Herald
16 hours ago
- Korea Herald
HLB appoints Brian Kim as CEO of US subsidary Elevar Therapeutics
Korean biopharmaceutical firm HLB said Wednesday it has appointed Brian Kim, current CEO of HLB Innovation and Verismo Therapeutics, as CEO of its US subsidiary, Elevar Therapeutics. Kim will lead all three companies concurrently. HLB said the leadership change is a strategic move to align with the skills needed at each stage of drug development, particularly as Elevar prepares to enter the commercialization phase and expand global partnerships with big pharma. Kim holds extensive experience in finance, strategic business management and biotechnology, including research in CAR-T cancer treatments and founding multiple biotech firms. A former tenured clinical professor at the University of Pennsylvania School of Dental Medicine, Kim was a founding member of Nasdaq-listed Inovio Pharmaceuticals. He has invested in various businesses, including acquiring a Kospi-listed company and elevating it into the Kospi 200 index. Kim also has invested in and led several biotech ventures in both the US and Korea. 'I feel a deep sense of responsibility taking on this role at such a pivotal moment,' Kim said. 'My focus will be on securing regulatory approval for Elevar's lead liver cancer therapy and ensuring its successful commercialization, while driving sustainable growth for the company.' HLB added that Kim's leadership will help accelerate Elevar's global business expansion and innovation in oncology therapeutics.
![[Graphic News] Incheon National University ranks 9th in innovation](/_next/image?url=https%3A%2F%2Fwimg.heraldcorp.com%2Fnews%2Fcms%2F2025%2F08%2F05%2Fnews-p.v1.20250805.4802979ce1e2467295cec8dab639f645_T1.gif&w=3840&q=100)
![[Graphic News] Incheon National University ranks 9th in innovation](/_next/image?url=https%3A%2F%2Fall-logos-bucket.s3.amazonaws.com%2Fkoreaherald.com.png&w=48&q=75)
Korea Herald
05-08-2025
- Korea Herald
[Graphic News] Incheon National University ranks 9th in innovation
South Korea's Incheon National University has been ranked 9th in the 2025 World University Rankings for Innovation. Incheon excelled in several categories, placing 3rd in student mobility and openness, 4th in culture and values and 8th in funding for sustainability. This year's rankings considered a record 4,866 innovation programs submitted by 1,253 universities in 87 countries. The top three spots were awarded to Minerva University (US), Arizona State University (US) and Ecole 42 (France). Among Korean universities, Seoul National University and Hankuk University of Foreign Studies ranked 19th and 22nd, respectively, following Incheon.